Post-IPO Equity - X4 Pharmaceuticals - Jun 30, 2022 Funding Round Profile - Cointime

Bitcoin $99,053.46 +2.07%
Ethereum $3,370.85 +7.86%
BNB $629.57 +3.04%
Optimism $2.05 +20.55%
Arbitrum $0.79 +12.94%
Solana $259.16 +8.75%
Polygon $0.46 +6.01%
Cosmos $6.59 +5.52%
Avalanche $36.16 +7.18%

Bitcoin $99,053.46 +2.07%
Ethereum $3,370.85 +7.86%
BNB $629.57 +3.04%
Optimism $2.05 +20.55%
Arbitrum $0.79 +12.94%
Solana $259.16 +8.75%
Polygon $0.46 +6.01%
Cosmos $6.59 +5.52%
Avalanche $36.16 +7.18%

X4 Pharmaceuticals

company

Funding Round

Post-IPO Equity

Money Raised

$ 55M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Acorn Bioventures	-	Yes	-	Detail
Lumira Ventures	-	Yes	-	Detail
New Enterprise Associates	-	Yes	-	Detail
Hercules Capital	-	-	-	Detail
AXA Investment Managers	-	-	-	Detail
Bain Capital Life Sciences	-	-	-	Detail
OrbiMed	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Nov 16, 2017	Series A	0	Thynk Capital, LLC.	Detail
Mar 19, 2021	Post-IPO Equity	$ 55M	Abingworth,Altium Capital,etc.	Detail
Nov 16, 2017	Series B	$ 27M	Cormorant Asset Management	Detail
Dec 15, 2015	Series A	$ 37.49M	Cormorant Asset Management	Detail
Jan 1, 2014	Seed	0	SV Health Investors	Detail
Nov 17, 2017	IPO	0		Detail